First Time Loading...
A

Antares Pharma Inc
NASDAQ:ATRS

Watchlist Manager
Antares Pharma Inc
NASDAQ:ATRS
Watchlist
Price: 5.59 USD Market Closed
Updated: May 5, 2024

Antares Pharma Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Antares Pharma Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Antares Pharma Inc
NASDAQ:ATRS
Cash from Investing Activities
-$3.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
-$2.9B
CAGR 3-Years
48%
CAGR 5-Years
5%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$21.7B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.6B
CAGR 3-Years
-45%
CAGR 5-Years
-6%
CAGR 10-Years
-10%

See Also

What is Antares Pharma Inc's Cash from Investing Activities?
Cash from Investing Activities
-3.9m USD

Based on the financial report for Dec 31, 2021, Antares Pharma Inc's Cash from Investing Activities amounts to -3.9m USD.